Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models (Q40155669)

18 September 2017

title

Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models (English)

1 reference

18 September 2017

1 reference

1 reference

Sharon Melamed

1 reference

18 September 2017

Boaz Politi

1 reference

18 September 2017

Hagit Achdout

1 reference

18 September 2017

Hadas Tamir

1 reference

18 September 2017

Shlomo Lustig

1 reference

18 September 2017

Tomer Israely

1 reference

18 September 2017

Noam Erez

1 reference

18 September 2017

Ofir Israeli

1 reference

18 September 2017

Trevor Waner

1 reference

18 September 2017

Nir Paran

1 reference

18 September 2017

language of work or name

English

0 references

publication date

15 June 2017

1 reference

18 September 2017

1 reference

18 September 2017

1 reference

18 September 2017

1 reference

18 September 2017

page(s)

4245-4254

1 reference

Pathogenesis and potential antiviral therapy of complications of smallpox vaccination

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Vaccinia virus pathogenicity in atopic dermatitis is caused by allergen-induced immune response that prevents the antiviral cellular and humoral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Severe eczema vaccinatum in a household contact of a smallpox vaccinee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Smallpox vaccination: a review, part II. Adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Protective murine and human monoclonal antibodies against eczema vaccinatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Animal models of atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Functional polysaccharides from Grifola frondosa aqueous extract inhibit atopic dermatitis-like skin lesions in NC/Nga mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

NC/Nga mice: a mouse model for atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

The NC/Nga mouse: a model for atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Nonreplicating vaccinia vector efficiently expresses recombinant genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Products and substrate/template usage of vaccinia virus DNA primase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Classic paper: Fenner on the exanthemata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC/Nga mice in specific-pathogen-free condition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Vaccinia Ig ameliorates eczema vaccinatum in a murine model of atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Images in clinical medicine. Eczema vaccinatum--a timely reminder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.014

10.1016/J.VACCINE.2017.06.014

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference